Loading...
Loading...
Shares of Keryx Biopharmaceuticals, Inc
KERX are higher on the session by 6.70%, trading at $4.62.
Overall call volume is now running at 2.31x the daily average, with 67% of all calls traded being purchases on the offer. 1,245 contracts have traded on the session so far.
Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in